Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SCHIFFMAN, Mark")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 199

  • Page / 8
Export

Selection :

  • and

Integration of human papillomavirus vaccination, cytology, and human papillomavirus testingSCHIFFMAN, Mark.Cancer. 2007, Vol 111, Num 3, pp 145-153, issn 0008-543X, 9 p.Article

Colposcopy at a crossroadsJERONIMO, Jose; SCHIFFMAN, Mark.American journal of obstetrics and gynecology. 2006, Vol 195, Num 2, pp 349-353, issn 0002-9378, 5 p.Article

Human Papillomavirus Infection and the Multistage Carcinogenesis of Cervical Cancer : CANCER PRECURSOR LESIONSSCHIFFMAN, Mark; WENTZENSEN, Nicolas.Cancer epidemiology, biomarkers & prevention. 2013, Vol 22, Num 4, pp 553-560, issn 1055-9965, 8 p.Article

Interobserver reproducibility of cervical cytologic and histologic interpretations: Realistic estimates From the ASCUS-LSIL Triage StudySTOLER, Mark H; SCHIFFMAN, Mark.JAMA, the journal of the American Medical Association. 2001, Vol 285, Num 11, pp 1500-1508, issn 0098-7484Article

Cervical-Cancer Screening with Human Papillomavirus and Cytologic CotestingSCHIFFMAN, Mark; SOLOMON, Diane.The New England journal of medicine. 2013, Vol 369, Num 24, pp 2324-2331, issn 0028-4793, 8 p.Article

From Human Papillomavirus to Cervical CancerSCHIFFMAN, Mark; WENTZENSEN, Nicolas.Obstetrics and gynecology (New York. 1953). 2010, Vol 116, Num 1, pp 177-185, issn 0029-7844, 9 p.Article

Adding a test for human papillomavirus DNA to cervical-cancer screeningWRIGHT, Thomas C; SCHIFFMAN, Mark.The New England journal of medicine. 2003, Vol 348, Num 6, pp 489-490, issn 0028-4793, 2 p.Article

Human papillomavirus: Epidemiology and public health : HPV Testing: Are you ready for a new era in cervical screening?SCHIFFMAN, Mark; CASTLE, Philip E.Archives of pathology & laboratory medicine (1976). 2003, Vol 127, Num 8, pp 930-934, issn 0363-0153, 5 p.Conference Paper

Medication use, medical conditions, and the risk of human papillomavirus infection and subsequent cervical intraepithelial neoplasia 3 among women with mild cytologic abnormalitiesWANG, Sophia S; SCHIFFMAN, Mark.Cancer epidemiology, biomarkers & prevention. 2005, Vol 14, Num 2, pp 542-545, issn 1055-9965, 4 p.Article

Findings to date from the ASCUS-LSIL Triage Study (ALTS) : HPV Testing: Are you ready for a new era in cervical screening?SCHIFFMAN, Mark; SOLOMON, Diane.Archives of pathology & laboratory medicine (1976). 2003, Vol 127, Num 8, pp 946-949, issn 0363-0153, 4 p.Conference Paper

Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trialSOLOMON, Diane; SCHIFFMAN, Mark; TARONE, Robert et al.Journal of the National Cancer Institute. 2001, Vol 93, Num 4, pp 293-299, issn 0027-8874Article

ASCUS-LSIL Triage Study : Design, methods and characteristics of trial participantsSCHIFFMAN, Mark; ADRIANZA, M. Elena.Acta cytologica. 2000, Vol 44, Num 5, pp 726-742, issn 0001-5547Conference Paper

Effects of age and human papilloma viral load on colposcopy triage: Data from the randomized atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study (ALTS)SHERMAN, Mark E; SCHIFFMAN, Mark; COX, J. Thomas et al.Journal of the National Cancer Institute. 2002, Vol 94, Num 2, pp 102-107, issn 0027-8874Article

Qualification of ASCUS: A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage StudySHERMAN, Mark E; SOLOMON, Diane; SCHIFFMAN, Mark et al.American journal of clinical pathology. 2001, Vol 116, Num 3, pp 386-394, issn 0002-9173Article

The distribution of neoplasia arising on the cervix : Results from the ALTS trialGUIDO, Richard S; JERONIMO, Jose; SCHIFFMAN, Mark et al.American journal of obstetrics and gynecology. 2005, Vol 193, Num 4, pp 1331-1337, issn 0002-9378, 7 p.Article

Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancerCASTLE, Philip E; SCHIFFMAN, Mark; WHEELER, Cosette M et al.American journal of obstetrics and gynecology. 2004, Vol 191, Num 5, pp 1590-1597, issn 0002-9378, 8 p.Article

The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assaysSTOLER, Mark H; CASTLE, Philip E; SOLOMON, Diane et al.American journal of clinical pathology. 2007, Vol 127, Num 3, pp 335-337, issn 0002-9173, 3 p.Article

Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significanceSAFAEIAN, Mahboobeh; SOLOMON, Diane; WACHOLDER, Sholom et al.Obstetrics and gynecology (New York. 1953). 2007, Vol 109, Num 6, pp 1325-1331, issn 0029-7844, 7 p.Article

Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2CASTLE, Philip E; SCHIFFMAN, Mark; WHEELER, Cosette M et al.Obstetrics and gynecology (New York. 1953). 2009, Vol 113, Num 1, pp 18-25, issn 0029-7844, 8 p.Article

Does the interval between papanicolaou tests influence the quality of cytology?JERONIMO, Jose; KHAN, Michelle J; SCHIFFMAN, Mark et al.Cancer. 2005, Vol 105, Num 3, pp 133-138, issn 0008-543X, 6 p.Article

A Descriptive Analysis of Prevalent vs Incident Cervical Intraepithelial Neoplasia Grade 3 Following Minor Cytologic AbnormalitiesCASTLE, Philip E; GRAVITT, Patti E; WENTZENSEN, Nicolas et al.American journal of clinical pathology. 2012, Vol 138, Num 2, pp 241-246, issn 0002-9173, 6 p.Article

Predicting the Effect of Successful Human Papillomavirus Vaccination on Existing Cervical Cancer Prevention Programs in the United StatesCASTLE, Philip E; SOLOMON, Diane; SASLOW, Debbie et al.Cancer. 2008, Vol 113, Num 10, pp 3031-3035, issn 0008-543X, 5 p., SUPArticle

Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR : HPV102 and HPV106ZIGUI CHEN; SCHIFFMAN, Mark; HERRERO, Rolando et al.Journal of general virology. 2007, Vol 88, pp 2952-2955, issn 0022-1317, 4 p., 11Article

Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsyCOX, J. Thomas; SCHIFFMAN, Mark; SOLOMON, Diane et al.American journal of obstetrics and gynecology. 2003, Vol 188, Num 6, pp 1406-1412, issn 0002-9378, 7 p.Article

Evaluation of a multiplex panel of immune-related markers in cervical secretions: A methodologic studyKOSHIOL, Jill; SKLAVOS, Martha; HILDESHEIM, Allan et al.International journal of cancer (Print). 2014, Vol 134, Num 2, pp 411-425, issn 0020-7136, 15 p.Article

  • Page / 8